Rights and permissions
About this article
Cite this article
Evaluating EVR to PEG IFN-α-2b/ribavirin therapy worthwhile. Pharmacoecon. Outcomes News 491, 9 (2005). https://doi.org/10.2165/00151234-200504910-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504910-00017